Breast Cancer

Catherine Stier, a breast cancer survivor, discusses her new book "When A Kid Like Me Has Cancer" a story of how to talk about cancer with children.

More than half of the patients with breast cancer who took part in an education-only or exercise-based intervention program remained lymphedema free 18 months following surgery to remove one or more of their lymph nodes.

Premenopausal women with HR-positive, HER2-negative, lymph node-positive breast cancer and a risk for recurrence experienced benefits with chemotherapy plus endocrine therapy, with improvements in five-year invasive disease-free and overall survival.

In this phase 3 trial, Verzenio with endocrine therapy reduced the risk for invasive disease recurrence and death versus endocrine therapy alone for patients with high-risk, early hormone receptor–positive, HER2-negative breast cancer.

While breast cancer survivors had a 45% higher risk of going into preterm labor, there were no significant increased risks of congenital defects or other pregnancy or delivery complications.

Prior to receiving behavioral interventions, more than half of participating young survivors of breast cancer were considered clinically depressed. That number dropped to 30% after participants received mindfulness meditation and survivorship education classes.

Of note, the results indicated that patients with breast cancer who were younger than 60 and of Black or other race were more likely to experience under-recognized symptoms by their physician.

Recently presented data demonstrated that a combination of oral paclitaxel and Encequidar elicited promising results in patients with radiation-associated breast angiosarcoma.

Younger age, breast cancer diagnosis, Medicaid insurance and treatment type were associated with an increased risk for women becoming new chronic users of opioids or sedatives/hypnotics following mastectomy with reconstructive surgery.

This week on the “CURE Talks Cancer” podcast, we discuss the power of community with The Breasties co-founders Brianna Majsiak and Allie Brudner Brumel and how their own experiences with breast cancer brought them together.

Several factors may lead to prolonged treatment duration for breast cancer including socioeconomic status, race, and barriers to care.

A patient with cancer discusses how the compassionate and encouraging presence of oncology nurses makes a difference in their cancer journey.

A former oncologist discusses how yoga became a vital part of her recovery after a surprise breast cancer diagnosis.

A cancer survivor describes how her oncology nurse was by her side through her cancer journey as both a nurse, and her friend.

Women with breast cancer who undergo fertility preservation with breast cancer are more likely to give birth than those who do not, researchers report.

Despite a modest benefit in these patients, principal investigator Dr. Yuan Yuan said she is looking “forward to the future” with regards to therapies that integrate nonsteroidal selective androgen receptor modulators for this patient population.

A poem from a mother to her daughter after her breast cancer diagnosis.

The Food and Drug Administration has approved the combination of Keytruda (pembrolizumab) with chemotherapy for patients with locally recurrent unresectable or metastatic triple-negative breast cancer who have a PD-L1 expression.

In this episode of the “CURE Talks Cancer” podcast, we spoke with a couple that has been married for 41 years about their journey as patient and caregiver during two bouts of triple-negative breast cancer. The couple, Janice and Rex Cowden, also give others facing similar situations advice on how to persevere together.

A breast surgical oncologist at The University of Texas MD Anderson Cancer Center notes that while breast cancer screening can be delayed a few months, it should not be skipped altogether.

2020 has been a challenging year, especially for survivors and those with cancer, but you can look forward to the new year. You just have to imagine the possibilities.

Two sisters diagnosed with the same stage of breast cancer in the same spot three weeks apart take part in proton therapy trial, Mayo Clinic and Google Health partner to investigate the use of artificial intelligence in assisting with radiotherapy treatments and more from the weekly roundup of news and research happening in the cancer landscape.

In this episode of the “CURE Talks Cancer” podcast, we spoke with television journalist Katie Couric and Susan G. Komen CEO Paula Schneider about their experiences with cancer, and the advice they offered their pre-cancer selves.

A roundup of the latest news and updates for patients with breast cancer from CURE®.

October is Breast Cancer Awareness month and is deeply associated with the color pink, but it wasn't always like that. Here's how the breast cancer awareness movement began.

Treatments like kinase inhibitors are changing the options patient may have for when their breast cancer spreads to the brain.

The breast cancer patient advocacy movement that started in the 1950s pulled the disease out of the shadows, bringing patients’ options to light.

A group extends a hand to those affected by breast or reproductive cancers, especially younger previvors, patients and caregivers.

Paula Schneider, president and CEO of Susan G. Komen®, writes to her younger self on the lessons and challenges she faced as a patient with breast cancer.

Can mastectomy or lumpectomy be avoided in women with ductal carcinoma in situ?